Grants per year
- 50 - 64 out of 64 results
Search results
-
Finished
Prot #GA29144: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy And Safety Of Etrolizumab As An Induction And Maintenance Treatment For Patients With Moderately To Severely Active Crohn’s Disease
Hanauer, S. B. (PD/PI)
Quintiles, Inc., Genentech, Inc
2/17/16 → 5/30/23
Project: Research project
-
Prot #GA28951: An Open Label Extension And Safety Monitoring Study Of Moderate To Severe Ulcerative Colitis Patients Previously Enrolled In Etrolizumab Phase III Studies
Hanauer, S. B. (PD/PI)
Quintiles, Inc., Genentech, Inc
12/21/15 → 12/21/20
Project: Research project
-
Prot #M13-740: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are
Hanauer, S. B. (PD/PI)
12/9/15 → 12/9/18
Project: Research project
-
Identifying Critical Cellular Interactions for the Reversal of Inflammatory Bowel Disease
Hanauer, S. B. (PD/PI)
University of California, San Francisco, Kenneth Rainin Foundation
12/1/15 → 11/30/16
Project: Research project
-
Experimental and clinical studies of a novel antimicrobial peptide regulator of mycobiome commensalism in health and IBD
Hanauer, S. B. (PD/PI)
The University of Chicago, Kenneth Rainin Foundation
12/1/15 → 5/31/17
Project: Research project
-
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Serum-derived Bovine Immunoglobulin/Protein Isolate (SBI) on Clostridium Difficile (C.difficile) Infection (CDI) in Hospitalized Ulcerative Colitis (UC) Patients
Hanauer, S. B. (PD/PI)
6/18/15 → 6/18/18
Project: Research project
-
Prot #GA28950: Phase III, Double Blind, Placebo-Controlled, Multicenter Study Of The Efficacy And Safety Of Etrolizumab During Induction And Maintenance In Patients With Moderate To Severe Active Ulcerative Colitis Who Are Refractory To Or Intolerant Of T
Hanauer, S. B. (PD/PI)
Quintiles, Inc., Genentech, Inc
4/20/15 → 4/20/21
Project: Research project
-
Prot #GA29102: Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy (Maintenance Of Remission) And Safety Of Etrolizumab Compared With Placebo In Patients With Moderate To Severe Active Ulcerative Colitis Who
Hanauer, S. B. (PD/PI)
Quintiles, Inc., Genentech, Inc
3/17/15 → 3/17/21
Project: Research project
-
Prot #M14-115: A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regimens in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration
Hanauer, S. B. (PD/PI)
INC Research, LLC, AbbVie Inc.
12/30/14 → 12/30/21
Project: Research project
-
Prot #M14-033: A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
Hanauer, S. B. (PD/PI)
INC Research, LLC, AbbVie Inc.
12/23/14 → 12/23/21
Project: Research project
-
Mechanisms of B Cell Responses in Autoimmune Disease
Hanauer, S. B. (PD/PI)
Duke University, National Institute of Allergy and Infectious Diseases
1/1/14 → 4/30/16
Project: Research project
-
Mechanisms of B Cell Responses in Autoimmune Disease: D14-AUC02-NWU
Hanauer, S. B. (PD/PI) & Hanauer, S. B. (Subproject PI)
Duke University, National Institute of Allergy and Infectious Diseases
1/1/14 → 4/30/16
Project: Research project
-
Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response in Treatment of UC-MERIT-UC)
Hanauer, S. B. (PD/PI)
University of North Carolina at Chapel Hill, National Institute of Diabetes and Digestive and Kidney Diseases
1/1/14 → 6/30/16
Project: Research project